OncLive
Jeffrey Zonder, M.D., hematologist, medical oncologist, leader of the Multiple Myeloma and Amyloidosis Multidisciplinary Team (MDT) and member of the Hematology Oncology MDT at Karmanos, discusses the ongoing research in multiple myeloma treatment at the cancer center, including bispecific antibodies and CAR-T therapy.
Watch here.